Compare AIXI & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIXI | MOVE |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 8.9M |
| IPO Year | 2023 | 2021 |
| Metric | AIXI | MOVE |
|---|---|---|
| Price | $0.65 | $7.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 189.8K | ★ 2.5M |
| Earning Date | 12-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $70,314,315.00 | $500,000.00 |
| Revenue This Year | $26.84 | $1,460.71 |
| Revenue Next Year | N/A | $96.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.84 | N/A |
| 52 Week Low | $0.60 | $4.67 |
| 52 Week High | $6.65 | $69.68 |
| Indicator | AIXI | MOVE |
|---|---|---|
| Relative Strength Index (RSI) | 36.75 | 42.81 |
| Support Level | $0.64 | $8.56 |
| Resistance Level | $0.71 | $11.80 |
| Average True Range (ATR) | 0.08 | 1.07 |
| MACD | 0.01 | -0.54 |
| Stochastic Oscillator | 19.98 | 0.00 |
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.